Danshen Chuanxiongzizine Injection is indicated for the treatment of occlusive cerebrovascular disease and other ischemic cardiovascular diseases. Danshen Chuanxiongzizine Injection has anti-platelet aggregation, dilates coronary arteries, reduces blood viscosity, accelerates the flow rate of red blood cells, improves microcirculation, and has antimyocardial ischemia and myocardial infarction effects. The drug can be used in the treatment of occlusive cerebrovascular diseases, such as cerebral blood supply insufficiency, cerebral thrombosis, cerebral embolism; it can also be used in other ischemic cardiovascular diseases, such as chest tightness of coronary heart disease, angina pectoris, myocardial infarction, ischemic stroke, thromboembolic vasculitis. Danshen Chuanxiongzizine Injection may have adverse reactions such as rash, itching, flushing, chills, laryngeal edema and dyspnea. It is contraindicated for those who are allergic to Danshen and Chuanxiongzizine preparations and excipients listed in the ingredients. Contraindicated in neonates, infants, pregnant and lactating women. Bleeding and patients with bleeding tendency are prohibited. Anaphylaxis is rare with Danshen Chuanxiongzizine Injection, and allergic reactions or other serious adverse reactions after administration should be discontinued immediately and treated promptly. Intravenous drip speed should not be too fast. Diabetic patients can use the drug under the guidance of a doctor. Danshen Chuanxiongzizine Injection is a prescription drug and is recommended to be used in accordance with medical advice.